SNCA - Seneca Biopharma, Inc.

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Get access to 40+ years of historical data with Yahoo Finance Premium.Learn more
Currency in USD

Valuation Measures

Premium required to access annual data
Annual
Quarterly
Premium required to access monthly data
Monthly
Subscribe to Premium to download historical data
 
As of Date: 7/2/2020
Current
3/31/202012/31/20199/30/20196/30/2019
Market Cap (intraday) 5
12.71M6.24M3.83M4.71M5.88M
Enterprise Value 3
2.94M1.54M-2.92M2.43M1.89M
Trailing P/E
N/AN/AN/AN/AN/A
Forward P/E 1
N/AN/AN/AN/AN/A
PEG Ratio (5 yr expected) 1
N/AN/AN/AN/AN/A
Price/Sales (ttm)
155.5794.5175.7292.8518.02
Price/Book (mrq)
1.271.220.542.401.81
Enterprise Value/Revenue 3
155.64256.24-1.17k972.19239.28
Enterprise Value/EBITDA 6
-0.23-0.201.46-1.41-1.35

Trading Information

Stock Price History

Beta (5Y Monthly) 1.71
52-Week Change 3-88.94%
S&P500 52-Week Change 35.18%
52 Week High 39.8900
52 Week Low 30.5000
50-Day Moving Average 30.8609
200-Day Moving Average 30.8812

Share Statistics

Avg Vol (3 month) 33.12M
Avg Vol (10 day) 3483.46k
Shares Outstanding 517.3M
Float 8.86M
% Held by Insiders 14.21%
% Held by Institutions 17.44%
Shares Short (Jun 14, 2020) 451.34k
Short Ratio (Jun 14, 2020) 40.01
Short % of Float (Jun 14, 2020) 40.30%
Short % of Shares Outstanding (Jun 14, 2020) 40.30%
Shares Short (prior month May 14, 2020) 442.64k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 21:20
Last Split Date 3Jul 17, 2019

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2019
Most Recent Quarter (mrq)Mar 30, 2020

Profitability

Profit Margin 0.00%
Operating Margin (ttm)-42,632.93%

Management Effectiveness

Return on Assets (ttm)-60.12%
Return on Equity (ttm)-193.41%

Income Statement

Revenue (ttm)18.91k
Revenue Per Share (ttm)0.00
Quarterly Revenue Growth (yoy)140.80%
Gross Profit (ttm)15.39k
EBITDA -7.93M
Net Income Avi to Common (ttm)-12.81M
Diluted EPS (ttm)N/A
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)10.03M
Total Cash Per Share (mrq)1.06
Total Debt (mrq)262.85k
Total Debt/Equity (mrq)2.63
Current Ratio (mrq)8.82
Book Value Per Share (mrq)N/A

Cash Flow Statement

Operating Cash Flow (ttm)-7.27M
Levered Free Cash Flow (ttm)-4.3M